182 related articles for article (PubMed ID: 16406448)
21. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
Piao ZZ; Lee MK; Lee BJ
Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
[TBL] [Abstract][Full Text] [Related]
22. Effect of pH and complexation on transdermal permeation of gliquidone.
Sridevi S; Diwan PV
Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
[TBL] [Abstract][Full Text] [Related]
23. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
24. A stable water-soluble tetramethylbenzidine-2-hydroxypropyl-beta-cyclodextrin inclusion complex and its applications in enzyme assays.
Cattaneo MV; Luong JH
Anal Biochem; 1994 Dec; 223(2):313-20. PubMed ID: 7887477
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
26. Effect of binary and ternary polyvinylpyrrolidone and/or hydroxypropyl-beta-cyclodextrin complexes on the photochemical and photosensitizing properties of Naproxen.
Valero M; Esteban B
J Photochem Photobiol B; 2004 Oct; 76(1-3):95-102. PubMed ID: 15488720
[TBL] [Abstract][Full Text] [Related]
27. Kinetic measurements of the hydrolytic degradation of cefixime: effect of Captisol complexation and water-soluble polymers.
Mallick S; Mondal A; Sannigrahi S
J Pharm Pharmacol; 2008 Jul; 60(7):833-41. PubMed ID: 18549669
[TBL] [Abstract][Full Text] [Related]
28. Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.
Saetern AM; Nguyen NB; Bauer-Brandl A; Brandl M
Int J Pharm; 2004 Oct; 284(1-2):61-8. PubMed ID: 15454297
[TBL] [Abstract][Full Text] [Related]
29. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
30. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
[TBL] [Abstract][Full Text] [Related]
32. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
33. Diffusion of naproxen in presence of beta-cyclodextrin across a silicone rubber membrane.
Orienti I; Fini A; Zecchi V; Zuman P
Pharm Acta Helv; 1991; 66(7):204-8. PubMed ID: 1763095
[TBL] [Abstract][Full Text] [Related]
34. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
[TBL] [Abstract][Full Text] [Related]
35. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
36. Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.
Lu Y; Tang N; Qi J; Wu W
Pharm Dev Technol; 2012; 17(2):236-41. PubMed ID: 21067338
[TBL] [Abstract][Full Text] [Related]
37. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
[TBL] [Abstract][Full Text] [Related]
38. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
Ventura CA; Giannone I; Paolino D; Pistarà V; Corsaro A; Puglisi G
Eur J Med Chem; 2005 Jul; 40(7):624-31. PubMed ID: 15935897
[TBL] [Abstract][Full Text] [Related]
39. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
Loftsson T
Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
[TBL] [Abstract][Full Text] [Related]
40. Effect of surfactant mixing on partitioning of model hydrophobic drug, naproxen, between aqueous and micellar phases.
Bhat PA; Rather GM; Dar AA
J Phys Chem B; 2009 Jan; 113(4):997-1006. PubMed ID: 19123827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
